VAN SCOYOC ASSOCIATES for RNACEUTICALS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
COVID-19 Vaccine research and development issues as follows: Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act Future COVID-19 related legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARLISLE CLARKE | *No lobby activity or contact made to US Senate Members and Staff thru 7/19/2020 |
| CHAD SCHULKEN | — |
Budget/Appropriations BUD
COVID-19 Vaccine research and development issues as follows: Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act Future COVID-19 related legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARLISLE CLARKE | *No lobby activity or contact made to US Senate Members and Staff thru 7/19/2020 |
| CHAD SCHULKEN | — |
Defense DEF
COVID-19 Vaccine research and development issues as follows: Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R.6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act Future COVID-19 related legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARLISLE CLARKE | *No lobby activity or contact made to US Senate Members and Staff thru 7/19/2020 |
| CHAD SCHULKEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.